Skip to Content

Boiron SA BOIRF

Morningstar Rating
$38.47 −7.75 (16.77%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BOIRF is trading at a 19% discount.
Price
$38.32
Fair Value
$14.78
Uncertainty
High
1-Star Price
$54.78
5-Star Price
$41.82
Economic Moat
Qprmc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BOIRF is a good fit for your portfolio.

Trading Information

Previous Close Price
$46.22
Day Range
$38.4738.52
52-Week Range
$38.4753.50
Bid/Ask
$37.81 / $40.33
Market Cap
$668.47 Mil
Volume/Avg
200 / 451

Key Statistics

Price/Earnings (Normalized)
13.01
Price/Sales
1.23
Dividend Yield (Trailing)
3.08%
Dividend Yield (Forward)
3.31%
Total Yield
3.09%

Company Profile

Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
2,813

Comparables

Valuation

Metric
BOIRF
VETO
HROW
Price/Earnings (Normalized)
13.0114.48
Price/Book Value
1.122.395.33
Price/Sales
1.232.303.10
Price/Cash Flow
14.4712.7232.95
Price/Earnings
BOIRF
VETO
HROW

Financial Strength

Metric
BOIRF
VETO
HROW
Quick Ratio
2.491.654.86
Current Ratio
3.322.685.80
Interest Coverage
49.0671.000.28
Quick Ratio
BOIRF
VETO
HROW

Profitability

Metric
BOIRF
VETO
HROW
Return on Assets (Normalized)
5.80%9.71%−1.23%
Return on Equity (Normalized)
8.17%12.86%−8.12%
Return on Invested Capital (Normalized)
7.38%12.34%6.71%
Return on Assets
BOIRF
VETO
HROW
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHkpb$90.3 Bil
MKKGY
Merck KGaA ADRVcdgyr$74.8 Bil
HLN
Haleon PLC ADRVctw$38.3 Bil
VTRS
Viatris IncNvz$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVffpj$13.0 Bil
CTLT
Catalent IncCzrmfxk$10.6 Bil
PRGO
Perrigo Co PLCWch$4.4 Bil
CURLF
Curaleaf Holdings IncFymh$3.9 Bil
PBH
Prestige Consumer Healthcare IncMsgdbx$3.5 Bil
GTBIF
Green Thumb Industries IncKgh$3.4 Bil

Sponsor Center